Research Results from Memorial Sloan-Kettering Cancer Center Update Understanding of Prostate Cancer [Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer ...]

Press/Media

Period	19 Apr 2023

Media coverage

Title	Research Results from Memorial Sloan-Kettering Cancer Center Update Understanding of Prostate Cancer [Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer ...]
Media name/outlet	Clinical Oncology Daily
Country/Territory	United States
Date	19/04/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=6823-8DJ1-DY7R-R24G-00000-00
Persons	Michael Morris